» Articles » PMID: 30109259

Overexpression of MicroRNA-34a Attenuates Proliferation and Induces Apoptosis in Pituitary Adenoma Cells Via SOX7

Overview
Publisher Cell Press
Date 2018 Aug 16
PMID 30109259
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Pituitary adenomas constitute one of the most common intracranial tumors and are typically benign. However, the role of the tumor suppressor microRNA-34a (miR-34a), which is implicated in other cancers, in pituitary adenoma pathogenesis remains largely unknown. miR-34a expression was compared between GH4C1 cancer cells and normal cells derived from the pituitary gland of , and the effects of miR-34a on GH4C1 cell proliferation and apoptosis were examined. miR-34a target genes were identified and analyzed computationally. The mRNA levels of the miR-34a target genes were measured using qRT-PCR, and the protein levels of the differentially expressed targets were assessed by western blotting. miR-34a expression was significantly lower in GH4C1 cells, whereas miR-34a overexpression significantly inhibited GH4C1 cell proliferation and promoted cell apoptosis though SRY-box 7 (SOX). Our data facilitate the development of a better understanding of the pathogenesis and treatment of pituitary adenomas by elucidating the crucial role of miR-34a in the development of pituitary adenomas.

Citing Articles

Emerging Roles of miRNA, lncRNA, circRNA, and Their Cross-Talk in Pituitary Adenoma.

Wu W, Cao L, Jia Y, Xiao Y, Zhang X, Gui S Cells. 2022; 11(18).

PMID: 36139495 PMC: 9496700. DOI: 10.3390/cells11182920.


[Differences in plasma miRNA levels in inferior petrosal sinus samples of patients with ACTH-dependent Cushing's syndrome].

Malygina A, Belaya Z, Nikitin A, Koshkin P, Sitkin I, Lapshina A Probl Endokrinol (Mosk). 2022; 67(6):18-30.

PMID: 35018758 PMC: 9753808. DOI: 10.14341/probl12817.


The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.

Ghafouri-Fard S, Abak A, Hussen B, Taheri M, Sharifi G Cancers (Basel). 2021; 13(23).

PMID: 34885097 PMC: 8656547. DOI: 10.3390/cancers13235987.


MicroRNAs as Potential Biomarkers in Pituitary Adenomas.

Donati S, Aurilia C, Palmini G, Miglietta F, Falsetti I, Iantomasi T Noncoding RNA. 2021; 7(3).

PMID: 34564317 PMC: 8482103. DOI: 10.3390/ncrna7030055.


Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer.

Sun R, Liu J, Nie S, Li S, Yang J, Jiang Y Onco Targets Ther. 2021; 14:2363-2378.

PMID: 33854334 PMC: 8039850. DOI: 10.2147/OTT.S272222.


References
1.
Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli M, Degli Uberti E . miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol. 2005; 204(1):280-5. DOI: 10.1002/jcp.20282. View

2.
Stine Z, Walton Z, Altman B, Hsieh A, Dang C . MYC, Metabolism, and Cancer. Cancer Discov. 2015; 5(10):1024-39. PMC: 4592441. DOI: 10.1158/2159-8290.CD-15-0507. View

3.
Zhang D, Zhou J, Dong M . Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF. Dig Dis Sci. 2013; 59(5):958-67. DOI: 10.1007/s10620-013-2983-4. View

4.
Stovall D, Wan M, Miller L, Cao P, Maglic D, Zhang Q . The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013; 183(5):1645-1653. PMC: 3814686. DOI: 10.1016/j.ajpath.2013.07.025. View

5.
Cristina C, Luque G, Demarchi G, Lopez Vicchi F, Zubeldia-Brenner L, Perez Millan M . Angiogenesis in pituitary adenomas: human studies and new mutant mouse models. Int J Endocrinol. 2014; 2014:608497. PMC: 4251882. DOI: 10.1155/2014/608497. View